Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Q3 2025 value amounting to $4.2 million.

  • Orchestra BioMed Holdings' Non-cash Items rose 2737.78% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 2737.78%. This contributed to the annual value of $3.5 million for FY2024, which is 5739.36% down from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Non-cash Items stood at $4.2 million, which was up 2737.78% from $8.3 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Non-cash Items registered a high of $9.0 million during Q1 2024, and its lowest value of $2.4 million during Q3 2023.
  • Over the past 3 years, Orchestra BioMed Holdings' median Non-cash Items value was $4.2 million (recorded in 2025), while the average stood at $5.4 million.
  • The largest annual percentage gain for Orchestra BioMed Holdings' Non-cash Items in the last 5 years was 18095.92% (2025), contrasted with its biggest fall of 5942.82% (2025).
  • Orchestra BioMed Holdings' Non-cash Items (Quarter) stood at $8.2 million in 2023, then plummeted by 57.39% to $3.5 million in 2024, then rose by 20.77% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $8.3 million for Q2 2025, and $3.7 million during Q1 2025.